{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:35Z","timestamp":1793414135268,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013894","name":"Polskiego Towarzystwa Kardiologicznego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013894","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.chest.2024.10.051","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T18:09:18Z","timestamp":1731175758000},"page":"1171-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of \u03b2-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions"],"prefix":"10.1016","volume":"167","author":[{"given":"Marcin","family":"Walig\u00f3ra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-469X","authenticated-orcid":false,"given":"Marcin","family":"Kurzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5282-1570","authenticated-orcid":false,"given":"Tatiana","family":"Mularek-Kubzdela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Skoczylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"B\u0142aszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Jaguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ptaszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mizia-Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Peregud-Pogorzelska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-2659","authenticated-orcid":false,"given":"Ewa","family":"Lewicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-9788","authenticated-orcid":false,"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-9645","authenticated-orcid":false,"given":"Micha\u0142","family":"Florczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mroczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Betkier-Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9768-0000","authenticated-orcid":false,"given":"Piotr","family":"Pruszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Widejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142awa","family":"Zab\u0142ocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-2801","authenticated-orcid":false,"given":"Grzegorz","family":"Kope\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.chest.2024.10.051_bib1","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1093\/cvr\/cvad121","article-title":"Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial","volume":"119","author":"Kope\u0107","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"16","key":"10.1016\/j.chest.2024.10.051_bib2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2024.10.051_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01107-2023","article-title":"Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial","volume":"62","author":"Souza","year":"2023","journal-title":"Eur Respir J"},{"issue":"36","key":"10.1016\/j.chest.2024.10.051_bib4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"33","key":"10.1016\/j.chest.2024.10.051_bib5","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.chest.2024.10.051_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.chest.2024.10.051_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.chest.2024.10.051_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.chest.2024.10.051_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/jcm9010173","article-title":"Characterization of patients with pulmonary arterial hypertension: data from the Polish Registry of Pulmonary Hypertension (BNP-PL)","volume":"9","author":"Kope\u0107","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.chest.2024.10.051_bib10","doi-asserted-by":"crossref","first-page":"2102024","DOI":"10.1183\/13993003.02024-2021","article-title":"Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry","volume":"59","author":"Hoeper","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2024.10.051_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.chest.2024.10.051_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/13993003.00090-2016","article-title":"Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study","volume":"48","author":"Van Campen","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2024.10.051_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cvr\/cvm008","article-title":"Beta-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent beta2 component in pulmonary hypertension","volume":"77","author":"Leblais","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.chest.2024.10.051_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1183\/09031936.06.00042705","article-title":"Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2024.10.051_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003703","article-title":"Use of \u03b2-blockers in pulmonary hypertension","volume":"10","author":"Perros","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.chest.2024.10.051_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijcard.2015.02.033","article-title":"Beta blocker for patients with pulmonary arterial hypertension: a single center experience","volume":"184","author":"Moretti","year":"2015","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.chest.2024.10.051_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2012.01.368","article-title":"Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension","volume":"109","author":"So","year":"2012","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.chest.2024.10.051_bib18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2014.11.050","article-title":"Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension","volume":"65","author":"Perros","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.chest.2024.10.051_bib19","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/rccm.201311-2025LE","article-title":"Treatment of group I pulmonary arterial hypertension with carvedilol is safe","volume":"189","author":"Grinnan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"38","key":"10.1016\/j.chest.2024.10.051_bib20","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.chest.2024.10.051_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.33963\/KP.14988","article-title":"Database of Pulmonary Hypertension in the Polish Population (BNP-PL): design of the registry","volume":"77","author":"Kope\u0107","year":"2019","journal-title":"Kardiol Pol"},{"issue":"1S","key":"10.1016\/j.chest.2024.10.051_bib23","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.chest.2019.10.064","article-title":"Statistical analysis and reporting guidelines for CHEST","volume":"158","author":"Kattan","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2024.10.051_bib24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurjhf\/hfq062","article-title":"Exercise stroke volume and heart rate response differ in right and left heart failure","volume":"12","author":"Groepenhoff","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.chest.2024.10.051_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1164\/rccm.200912-1856OC","article-title":"Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension","volume":"181","author":"Ciarka","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2024.10.051_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00144-2023","article-title":"Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension","volume":"61","author":"Samaranayake","year":"2023","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2024.10.051_bib27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/CIRCHEARTFAILURE.114.001429","article-title":"\u03b2-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis","volume":"7","author":"Thenappan","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.chest.2024.10.051_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00215514","article-title":"Outcomes of \u03b2-blocker use in pulmonary arterial hypertension: a propensity-matched analysis","volume":"46","author":"Bandyopadhyay","year":"2015","journal-title":"Eur Respir J"},{"issue":"14","key":"10.1016\/j.chest.2024.10.051_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021518","article-title":"Carvedilol for treatment of right ventricular dysfunction in pulmonary arterial hypertension","volume":"10","author":"Thenappan","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.chest.2024.10.051_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95240","article-title":"Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial","volume":"2","author":"Farha","year":"2017","journal-title":"JCI Insight"},{"issue":"8885","key":"10.1016\/j.chest.2024.10.051_bib31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"issue":"9377","key":"10.1016\/j.chest.2024.10.051_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.chest.2024.10.051_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224054710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224054710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:03:17Z","timestamp":1747857797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224054710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0012369224054710"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.10.051","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of \u03b2-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}